This edition of Citizen Today includes insights on the education market from Parthenon-EY Managing Directors Amit Garga, Karan Khemka, Haven Ladd, Robert Lytle and Matthew Robb.
Inorganic strategies are driving the digital agenda in life sciences.
Watch Parthenon-EY Managing Director and Co-head of Health Care Dan Shoenholz and EY Partner Arda Ural discuss growth themes in medtech in 2017.
Parthenon-EY’s in-depth research shows where and how companies can harness shareholder activists’ tactics for competitive advantage.
New technologies, customers and competition are forcing — and enabling — biopharmaceutical companies to find novel ways to create and capture value.
Parthenon-EY’s Education practice assesses the potential impact of early college high schools using data and perspectives from Massachusetts and around the country.
Listen to Jay Bartlett and Scott Orleck on this podcast sharing their experiences and takeaways from buy-side due diligence projects.
The Parthenon-EY team is committed to bringing unconventional yet pragmatic thinking together with our clients’ smarts to deliver actionable strategies for real impact in today’s complex business landscape.